Skip to main content

Web Exclusives

FDA Approvals
Hepzato Kit FDA Approved as a Liver-Directed Treatment for Uveal Melanoma With Hepatic Metastases
Read More
FDA Approvals
Gavreto Received Regular FDA Approval for Patients With Non–Small Cell Lung Cancer and RET Gene Fusion
Read More
Original Research, Practice Management
Employer Disability and Workers’ Compensation Trends for Their Employees With Ophthalmic Conditions in the United States
Richard A. Brook, MS, MBA; Nathan L. Kleinman, PhD; Ian A. Beren, BS
Read More
Disparities in Cancer Care, Urothelial Cancer, Oncology
Addressing Health Equity in Bladder Cancer Care
William King
Read More
FDA Approvals
Lonsurf Received a New Indication, in Combination With Bevacizumab, for Previously Treated Metastatic Colorectal Cancer
Read More
FDA Approvals
Jemperli Plus Chemotherapy Now FDA Approved for Front-Line Treatment of dMMR or MSI-H Endometrial Cancer
Read More
In the News
Tornado Sweeps Through Pfizer’s Storage and Manufacturing Facility
Read More
FDA Approvals
Vanflyta Now Approved for Newly Diagnosed FLT3-ITD–Positive AML
Read More
In the News, Technology
Acceptance of Artificial Intelligence in Healthcare Is Making Inroads
Read More
Original Research
Cost-Savings Using Patients’ Own Medication Supply of Letermovir for Allogeneic Hematopoietic Stem-Cell Transplant Recipients During Hospitalization
Harrison S. Yoon, PharmD; Mallory Crain, PharmD, BCOP; Marissa Olson, PharmD, BCOP; Anupam Pande, MD, MPH; Jeff O. Klaus, PharmD, BCPS
Read More
Page 6 of 37
Results 51 - 60 of 362